View Item 

Show simple item record

Neurofilament is superior to cytokeratin 20 in supporting cutaneous origin for neuroendocrine carcinoma
dc.contributor.authorStanoszek, Lauren M
dc.contributor.authorChan, May P
dc.contributor.authorPalanisamy, Nallasivam
dc.contributor.authorCarskadon, Shannon
dc.contributor.authorSiddiqui, Javed
dc.contributor.authorPatel, Rajiv M
dc.contributor.authorHarms, Kelly L
dc.contributor.authorLowe, Lori
dc.contributor.authorFullen, Douglas R
dc.contributor.authorHarms, Paul W
dc.date.accessioned2019-02-12T20:23:32Z
dc.date.available2020-04-01T15:06:24Zen
dc.date.issued2019-02
dc.identifier.citationStanoszek, Lauren M; Chan, May P; Palanisamy, Nallasivam; Carskadon, Shannon; Siddiqui, Javed; Patel, Rajiv M; Harms, Kelly L; Lowe, Lori; Fullen, Douglas R; Harms, Paul W (2019). "Neurofilament is superior to cytokeratin 20 in supporting cutaneous origin for neuroendocrine carcinoma." Histopathology 74(3): 504-513.
dc.identifier.issn0309-0167
dc.identifier.issn1365-2559
dc.identifier.urihttps://hdl.handle.net/2027.42/147795
dc.publisherWiley Periodicals, Inc.
dc.subject.othersentinel lymph node
dc.subject.othersmall‐cell carcinoma
dc.subject.othercytokeratin 20
dc.subject.otherMerkel cell polyomavirus
dc.subject.otherneuroendocrine carcinoma
dc.subject.otherneurofilament
dc.subject.otherMerkel cell carcinoma
dc.titleNeurofilament is superior to cytokeratin 20 in supporting cutaneous origin for neuroendocrine carcinoma
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelMicrobiology and Immunology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/147795/1/his13758.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/147795/2/his13758_am.pdf
dc.identifier.doi10.1111/his.13758
dc.identifier.sourceHistopathology
dc.identifier.citedreferenceLeech SN, Kolar AJ, Barrett PD, Sinclair SA, Leonard N. Merkel cell carcinoma can be distinguished from metastatic small cell carcinoma using antibodies to cytokeratin 20 and thyroid transcription factor 1. J. Clin. Pathol. 2001; 54; 727 – 729.
dc.identifier.citedreferenceRalston J, Chiriboga L, Nonaka D. MASH1: a useful marker in differentiating pulmonary small cell carcinoma from Merkel cell carcinoma. Mod. Pathol. 2008; 21; 1357 – 1362.
dc.identifier.citedreferenceCheuk W, Kwan MY, Suster S, Chan JK. Immunostaining for thyroid transcription factor 1 and cytokeratin 20 aids the distinction of small cell carcinoma from Merkel cell carcinoma, but not pulmonary from extrapulmonary small cell carcinomas. Arch. Pathol. Lab. Med. 2001; 125; 228 – 231.
dc.identifier.citedreferenceMertz KD, Paasinen A, Arnold A et al. Merkel cell polyomavirus large T antigen is detected in rare cases of nonmelanoma skin cancer. J. Cutan. Pathol. 2013; 40; 543 – 549.
dc.identifier.citedreferenceOta S, Ishikawa S, Takazawa Y et al. Quantitative analysis of viral load per haploid genome revealed the different biological features of Merkel cell polyomavirus infection in skin tumor. PLoS ONE 2012; 7; e39954.
dc.identifier.citedreferenceLy TY, Walsh NM, Pasternak S. The spectrum of Merkel cell polyomavirus expression in Merkel cell carcinoma, in a variety of cutaneous neoplasms, and in neuroendocrine carcinomas from different anatomical sites. Hum. Pathol. 2012; 43; 557 – 566.
dc.identifier.citedreferenceBusam KJ, Jungbluth AA, Rekthman N et al. Merkel cell polyomavirus expression in Merkel cell carcinomas and its absence in combined tumors and pulmonary neuroendocrine carcinomas. Am. J. Surg. Pathol. 2009; 33; 1378 – 1385.
dc.identifier.citedreferenceMiner AG, Patel RM, Wilson DA et al. Cytokeratin 20‐negative Merkel cell carcinoma is infrequently associated with the Merkel cell polyomavirus. Mod. Pathol. 2015; 28; 498 – 504.
dc.identifier.citedreferenceSu LD, Lowe L, Bradford CR, Yahanda AI, Johnson TM, Sondak VK. Immunostaining for cytokeratin 20 improves detection of micrometastatic Merkel cell carcinoma in sentinel lymph nodes. J. Am. Acad. Dermatol. 2002; 46; 661 – 666.
dc.identifier.citedreferenceGould VE, Bloom KJ, Franke WW, Warren WH, Moll R. Increased numbers of cytokeratin‐positive interstitial reticulum cells (CIRC) in reactive, inflammatory and neoplastic lymphadenopathies: hyperplasia or induced expression? Virchows Arch. 1995; 425; 617 – 629.
dc.identifier.citedreferenceOlson NJ, Perry AE, Linos K. Cytokeratin‐positive fibroblastic reticular cell: a pitfall for dermatopathologists assessing lymph nodes for Merkel cell carcinoma. J. Cutan. Pathol. 2016; 43; 1231 – 1233.
dc.identifier.citedreferenceMoll R, Lowe A, Laufer J, Franke WW. Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. Am. J. Pathol. 1992; 140; 427 – 447.
dc.identifier.citedreferenceSchmidt U, Muller U, Metz KA, Leder LD. Cytokeratin and neurofilament protein staining in Merkel cell carcinoma of the small cell type and small cell carcinoma of the lung. Am. J. Dermatopathol. 1998; 20; 346 – 351.
dc.identifier.citedreferenceKontochristopoulos GJ, Stavropoulos PG, Krasagakis K, Goerdt S, Zouboulis CC. Differentiation between Merkel cell carcinoma and malignant melanoma: an immunohistochemical study. Dermatology 2000; 201; 123 – 126.
dc.identifier.citedreferenceLlombart B, Monteagudo C, Lopez‐Guerrero JA et al. Clinicopathological and immunohistochemical analysis of 20 cases of Merkel cell carcinoma in search of prognostic markers. Histopathology 2005; 46; 622 – 634.
dc.identifier.citedreferenceSur M, AlArdati H, Ross C, Alowami S. TdT expression in Merkel cell carcinoma: potential diagnostic pitfall with blastic hematological malignancies and expanded immunohistochemical analysis. Mod. Pathol. 2007; 20; 1113 – 1120.
dc.identifier.citedreferenceOrdonez NG. Value of thyroid transcription factor‐1 immunostaining in distinguishing small cell lung carcinomas from other small cell carcinomas. Am. J. Surg. Pathol. 2000; 24; 1217 – 1223.
dc.identifier.citedreferenceNCCN Clinical Practice Guidelines in Oncology, Merkel Cell Carcinoma Version I.2018. 2017. Available at: https://www.nccn.org/professionals/physician_gls/pdf/mcc.pdf [Accessed December 17, 2017].
dc.identifier.citedreferenceMcCalmont TH. Paranuclear dots of neurofilament reliably identify Merkel cell carcinoma. J. Cutan. Pathol. 2010; 37; 821 – 823.
dc.identifier.citedreferenceChan JK, Suster S, Wenig BM, Tsang WY, Chan JB, Lau AL. Cytokeratin 20 immunoreactivity distinguishes Merkel cell (primary cutaneous neuroendocrine) carcinomas and salivary gland small cell carcinomas from small cell carcinomas of various sites. Am. J. Surg. Pathol. 1997; 21; 226 – 234.
dc.identifier.citedreferenceMcCluggage WG, Kennedy K, Busam KJ. An immunohistochemical study of cervical neuroendocrine carcinomas: neoplasms that are commonly TTF1 positive and which may express CK20 and P63. Am. J. Surg. Pathol. 2010; 34; 525 – 532.
dc.identifier.citedreferenceShah IA, Netto D, Schlageter MO, Muth C, Fox I, Manne RK. Neurofilament immunoreactivity in Merkel‐cell tumors: a differentiating feature from small‐cell carcinoma. Mod. Pathol. 1993; 6; 3 – 9.
dc.identifier.citedreferenceAcebo E, Vidaurrazaga N, Varas C, Burgos‐Bretones JJ, Diaz‐Perez JL. Merkel cell carcinoma: a clinicopathological study of 11 cases. J. Eur. Acad. Dermatol. Venereol. 2005; 19; 546 – 551.
dc.identifier.citedreferencePulitzer MP, Brannon AR, Berger MF et al. Cutaneous squamous and neuroendocrine carcinoma: genetically and immunohistochemically different from Merkel cell carcinoma. Mod. Pathol. 2015; 28; 1023 – 1032.
dc.identifier.citedreferenceHarms PW, Collie AM, Hovelson DH et al. Next generation sequencing of cytokeratin 20‐negative Merkel cell carcinoma reveals ultraviolet‐signature mutations and recurrent TP53 and RB1 inactivation. Mod. Pathol. 2016; 29; 240 – 248.
dc.identifier.citedreferenceFisher CA, Harms PW, McHugh JB et al. Small cell carcinoma in the parotid harboring Merkel cell polyomavirus. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 2014; 118; 703 – 712.
dc.identifier.citedreferenceChen Y, Klonowski PW, Lind AC, Lu D. Differentiating neurotized melanocytic nevi from neurofibromas using Melan‐A (MART‐1) immunohistochemical stain. Arch. Pathol. Lab. Med. 2012; 136; 810 – 815.
dc.identifier.citedreferenceJung HS, Choi YL, Choi JS et al. Detection of Merkel cell polyomavirus in Merkel cell carcinomas and small cell carcinomas by PCR and immunohistochemistry. Histol. Histopathol. 2011; 26; 1231 – 1241.
dc.identifier.citedreferencePaik JY, Hall G, Clarkson A et al. Immunohistochemistry for Merkel cell polyomavirus is highly specific but not sensitive for the diagnosis of Merkel cell carcinoma in the Australian population. Hum. Pathol. 2011; 42; 1385 – 1390.
dc.identifier.citedreferenceHarms PW, Patel RM, Verhaegen ME et al. Distinct gene expression profiles of viral‐ and nonviral‐associated Merkel cell carcinoma revealed by transcriptome analysis. J. Invest. Dermatol. 2013; 133; 936 – 945.
dc.identifier.citedreferenceHarms PW. Update on Merkel cell carcinoma. Clin. Lab. Med. 2017; 37; 485 – 501.
dc.identifier.citedreferenceHarms PW, Vats P, Verhaegen ME et al. The distinctive mutational spectra of polyomavirus‐negative Merkel cell carcinoma. Cancer Res. 2015; 75; 3720 – 3727.
dc.identifier.citedreferenceGoh G, Walradt T, Markarov V et al. Mutational landscape of MCPyV‐positive and MCPyV‐negative Merkel cell carcinomas with implications for immunotherapy. Oncotarget 2016; 7; 3403 – 3415.
dc.identifier.citedreferenceWong SQ, Waldeck K, Vergara IA et al. UV‐associated mutations underlie the etiology of MCV‐negative Merkel cell carcinomas. Cancer Res. 2015; 75; 5228 – 5234.
dc.identifier.citedreferenceFeng H, Shuda M, Chang Y, Moore PS. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008; 319; 1096 – 1100.
dc.identifier.citedreferenceHoucine Y, Chelly I, Zehani A et al. Neuroendocrine differentiation in basal cell carcinoma. J. Immunoassay Immunochem. 2017; 38; 487 – 493.
dc.identifier.citedreferencePanse G, McNiff JM, Ko CJ. Basal cell carcinoma: CD56 and cytokeratin 5/6 staining patterns in the differential diagnosis with Merkel cell carcinoma. J. Cutan. Pathol. 2017; 44; 553 – 556.
dc.identifier.citedreferenceBobos M, Hytiroglou P, Kostopoulos I, Karkavelas G, Papadimitriou CS. Immunohistochemical distinction between Merkel cell carcinoma and small cell carcinoma of the lung. Am. J. Dermatopathol. 2006; 28; 99 – 104.
dc.identifier.citedreferenceHanly AJ, Elgart GW, Jorda M, Smith J, Nadji M. Analysis of thyroid transcription factor‐1 and cytokeratin 20 separates Merkel cell carcinoma from small cell carcinoma of lung. J. Cutan. Pathol. 2000; 27; 118 – 120.
dc.identifier.citedreferenceSidiropoulos M, Hanna W, Raphael SJ, Ghorab Z. Expression of TdT in Merkel cell carcinoma and small cell lung carcinoma. Am. J. Clin. Pathol. 2011; 135; 831 – 838.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
his13758.pdf
Size:
473.3KB
Format:
PDF
View/Open
Name:
his13758_am.pdf
Size:
253.2KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.